Physician profile
Amanda J Schroeder
NPI 1275996423
$44,728.37
in general payments reported to CMS, 2019-2025
9 companies · $4,230 in 2025
The $4,230 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23K · 2022: $12K · 2023: $3,928 · 2024: $2,239 · 2025: $4,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,722 · Food and Beverage: $3,525 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,722.10 |
| Food and Beverage | $3,525.39 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $27,816.21 | 2021-2025 | |
| Foundation Medical, LLC | $6,576.33 | 2022-2025 | |
| Djo, LLC | $5,093.75 | 2021-2025 | Aircast, Donjoy |
| Medical Device Business Services, INC. | $2,484.07 | 2022 | |
| Zimmer Biomet Holdings, INC. | $2,063.72 | 2023-2024 | Comprehensive Shoulder System, Persona, Tapestry |
| Smith+Nephew, INC. | $310.37 | 2023 | Evos, Smart Tsf, Trigen Intertan |
| Stryker Corporation | $192.08 | 2023-2025 | Augment Injectable |
| Elite Orthopedics, LLC | $167.04 | 2022 | |
| Vericel Corporation | $24.80 | 2025 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Schroeder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.